Why the study?
Does quantitative MRI using mean pixel intensity (MPI) detect subclinical disease progression in patients with Facioscapulohumeral muscular dystrophy (FSHD) compared to clinical assessment tools?
Population
35 FSHD1 patients (17 females)
Design
Cohort
Follow-up
1 to 2 years
Authors
Loading...
Quantitative MRI using the MPItotal index can detect subclinical disease progression in FSHD over a short period, serving as a reliable biomarker when clinical scales show no significant change.
Does quantitative MRI using mean pixel intensity (MPI) detect subclinical disease progression in patients with Facioscapulohumeral muscular dystrophy (FSHD) compared to clinical assessment tools?
Quantitative MRI using the MPItotal index can detect subclinical disease progression in FSHD over a short period, serving as a reliable biomarker when clinical scales show no significant change.
Fatehi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: